To confirm the presence of these mutations in our batch of LNCaP cells, we extracted the genomic DNA from LNCaP and DU145 cells (the latter prostate cancer cell line served as a positive control since it is IFN-sensitive [17]). This evidence concerns the gene IFNA1 and prostate carcinoma.